Marine bacterial extracellular polysaccharides (EPS) represent a unique class of biopolymers with vast potential in biopharmaceutical research due to their diverse structural characteristics, functional properties, and biocompatibility. This study delves into the comprehensive analysis of the monosaccharide composition, molecular weight distribution, and conformational dynamics of marine bacterial EPS, employing advanced analytical techniques such as Nuclear Magnetic Resonance (NMR) spectroscopy, Mass Spectrometry (MS), and Size-Exclusion Chromatography coupled with Multi-Angle Laser Light Scattering (SEC-MALLS). Furthermore, we explore the functional applications of these EPS in biofilm inhibition, immunomodulation, and as innovative drug delivery systems, highlighting their role in enhancing antibiotic efficacy and mitigating resistance. Through quantitative analysis and mathematical modeling, including rheological studies and kinetic modeling of biodegradation, this work assesses the EPSs biocompatibility and biodegradability, essential for their safe use in biomedicine. Our findings underscore the potential of marine bacterial EPS in developing novel biopharmaceutical formulations that are not only effective but also environmentally sustainable and biocompatible, paving the way for future advancements in medical and therapeutic applications.